Dual cytotoxic mechanisms of submicromolar taxol on human leukemia HL- 60 cells

Biochemical Pharmacology

Volumn 53, Issue 11, 1997, Pages 1587-1596

  Lieu, Chien Hui ^a   Chang, Yen Ni ^a   Lai, Yiu Kay ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cytotoxicity; HL 60 cells; Mitotic block; Taxol

Indexed keywords

PACLITAXEL;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL STRAIN HL 60; CYTOTOXICITY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOSIS; PRIORITY JOURNAL;

EID: 0030737921     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)82450-1     Document Type: Article

References (37)

1. Wani MC, Taylor HL, Wall ME, Coggon P and McPhail AT, Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327, 1971.
2. McGuire WP, Rowinsky EK, Rosenshein NB, Gunmbine FC, Ettinger DS, Armstrong DK and Donehower RC, Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111: 273-279, 1989.
3. Reed E, Kohn EC, Sarosy G, Dabholkar M, Davis P, Jacob J and Maher M, Paclitaxel, cisplatin, and cyclophosphamide in human ovarian cancer: Molecular rationale and early clinical results. Semin Oncol 22: 90-96, 1995.
4. Rowinsky EK, Gilbert MR, McGuire WP, Noe DA, Grochow LB, Forastiere AA, Ettinger DS, Lubejko BG, Clark B, Sartorius SE, Cornblath DR, Hendricks CB and Donehower RC, Sequences of taxol and cisplatin: A phase I and pharmacologic study. J Clin Oncol 9: 1692-1703, 1991.
5. Wiernik PH, Schwartz EL, Einzig A, Strauman JJ, Lipton RB and Dutcher JP, Phase I trails of taxol given as a 24 hour infusion every 21 days: Responses observed in metastatic melanoma. J Clin Oncol 5: 1232-1239, 1987.
6. Rowinsky EK, Burke PJ, Karp JE, Tucker RW, Ettinger DS and Donehower RC, Phase I and pharmacodynamic study of taxol in refractory acute leukemias. Cancer Res 49: 4640-4647, 1989.
7. Schiff PB, Fant J and Horwitz SB, Promotion of microtubule assembly in vivo by taxol. Nature 22: 665-667, 1979.
8. Manfredi JJ and Horwitz SB, Taxol: An antimitotic agent with a new mechanism of action. Pharmacol Ther 25: 83-125, 1984.
9. Schiff PB and Horwitz SB, Taxol assembles tubulin in the absence of exogenous guanosine 5′-triphosphate or microtubule-associated proteins. Biochemistry 20: 3247-3252, 1981.
10. Thompson WC, Wilson L and Purich DL, Taxol induces microtubule assembly at low temperatures. Cell Motil 1: 445-454, 1981.
11. Long BH and Fairchild CR, Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res 54: 4355-4361, 1994.
12. Jordan MA, Toso RJ, Thrower D and Wilson L, Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 90: 9552-9556, 1993.
13. Schiff PB and Horwitz SB, Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77: 1561-1565, 1980.
14. Manfredi JJ, Parness J and Horwitz SB, Taxol binds to cellular microtubules. J Cell Biol 94: 688-696, 1982.
15. Donaldson KL, Goolsby GL and Wahl AF, Cytotoxicity of the anticancer agents cisplastin and taxol during cell proliferation and the cell cycle. Int J Cancer 57: 847-855, 1994.
16. Lopes NM, Adams EG, Pitts TW and Bhuyan BK, Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 32: 235-242, 1993.
17. Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME and Huang Y, Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7: 563-568, 1993.
18. Milas L, Hunter NR, Kurdoglu B, Mason KA, Meyn RE, Stephens LC and Peters LJ, Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother Pharmacol 35: 297-303, 1995.
19. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H and Wilson L, Mitotic block induced in HeLa cells by low concentrations of paclitaxel (taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56: 816-825, 1996.
20. Ray S, Ponnathpur V, Huang Y, Tang C, Mahoney ME, Ibrado AM, Bullock G and Bhalla K, 1-β-D-Arabinofuranosylcytosine-, mitoxantrone-, and palcitaxel-induced apoptosis in HL-60 cells: Improved method for detection of internucleosomal DNA fragmentation. Cancer Chemother Pharmacol 34: 365-371, 1994.
21. Rowinsky EK, Donehower RC, Jones RJ and Tucker RW, Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res 48: 4093-4110, 1988.
22. Roberts JR, Allison DC, Donehower RC and Rowinsky ER, Development of polyploidization in taxol-resistant human leukemic cells in vitro. Cancer Res 50: 710-716, 1990.
23. Loo BVD, Hong Y, Hancock V, Martin JF and Erusalonsky JD, Antimicrotubule agents induce polyploidization of human leukaemic cell lines with megakaryocytic features. Eur J Clin Invest 23: 621-629, 1993.
24. Liebmann J, Cook JA, Lipschultz C, Teague D, Fisher J and Mitchell JB, Influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol®) in human tumor cell lines. Cancer Chemother Pharmacol 33: 331-339, 1994.
25. Rosaria MR, Tiso GM, Marchetti C, Severi B and Fabbi M, Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother Pharmacol 36: 385-392, 1995.
26. Gallagher R, Collins S, Trujillo J, McCredie K, Ahearn M, Tsai S, Metzgar R, Aulakh G, Ting R, Ruscetti F and Gallo R, Characterization of the continuous differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54: 713-733, 1979.
27. Kerr JFR, Winterford CM and Harmon BV, Morphological criteria for identifying apoptosis. In: Cell Biology (Ed. Celis JE), Vol. 1, pp. 319-329. Academic Press, San Diego, 1994.
28. Gorczyca W, Gong J and Darzynkiewicz Z, Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53: 1945-1951, 1993.
29. Liesveld JL, Keng PC, Rowe JM, DiPersio JF and Abboud CN, Effects of GM-CSF on Ki67 expression and cell cycle traverse in acute myelogenous leukemia specimens and cell lines. Leuk Res 18: 609-616, 1994.
30. Terui Y, Furukawa Y, Kikuchi J and Saito M, Apoptosis during HL-60 cell differentiation is closely related to a G0/G1 cell cycle arrest. J Cell Physiol 164: 74-84, 1995.
31. cdc2 inactivation and mitotic exit in mammalian cells. J Cell Biol 127: 789-802, 1994.
32. Willingham MC and Bhalla K, Transit mitotic phase localization of bcl-2 oncoprotein in human carcinoma cells and its possible role in prevention of apoptosis. J Histochem Cytochem 42: 441-450, 1994.
33. Kung AL, Zetterberg A, Sherwood SW and Schimke RT, Cytotoxic effects of cell cycle phase specific agents: Results of cell cycle perturbation. Cancer Res 50: 7307-7317, 1990.
34. cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ 5: 1041-1050, 1994.
35. Tang C, Willingham MC, Reed JC, Miyashita T, Ray S, Ponnathpur V, Huang Y, Mahoney ME, Bullock G and Bhalla K, High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. Leukemia 8: 1960-1969, 1994.
36. Ponnathpur V, Ibrado AM, Reed JC, Ray S, Huang Y, Self S, Bullock G, Nawabi A and Bhalla K, Effects of modulators of protein kinases on Taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein. Clin Cancer Res 1: 1399-1406, 1995.
37. Parekh H and Simpkins H, Species-specific differences in taxol transport and cytotoxity against human and rodent cells. Biochem Pharmacol 51: 301-311, 1996.